Published in J Mol Cell Cardiol on July 13, 2011
Dynamic micro- and macrovascular remodeling in coronary circulation of obese Ossabaw pigs with metabolic syndrome. J Appl Physiol (1985) (2012) 1.02
Contribution of voltage-dependent K⁺ channels to metabolic control of coronary blood flow. J Mol Cell Cardiol (2011) 0.99
Impaired cardiometabolic responses to glucagon-like peptide 1 in obesity and type 2 diabetes mellitus. Basic Res Cardiol (2013) 0.99
Influence of obesity and metabolic dysfunction on the endothelial control in the coronary circulation. J Mol Cell Cardiol (2011) 0.87
Contribution of electromechanical coupling between Kv and Ca v1.2 channels to coronary dysfunction in obesity. Basic Res Cardiol (2013) 0.84
Endothelial regulation of coronary microcirculation in health and cardiometabolic diseases. Intern Emerg Med (2013) 0.83
Prostaglandin E Receptor Subtype 4 Signaling in the Heart: Role in Ischemia/Reperfusion Injury and Cardiac Hypertrophy. J Diabetes Res (2016) 0.80
Lean and Obese Coronary Perivascular Adipose Tissue Impairs Vasodilation via Differential Inhibition of Vascular Smooth Muscle K+ Channels. Arterioscler Thromb Vasc Biol (2015) 0.80
Leptin augments coronary vasoconstriction and smooth muscle proliferation via a Rho-kinase-dependent pathway. Basic Res Cardiol (2016) 0.76
Cardiovascular consequences of metabolic syndrome. Transl Res (2017) 0.75
Obesity alters molecular and functional cardiac responses to ischemia/reperfusion and glucagon-like peptide-1 receptor agonism. Basic Res Cardiol (2016) 0.75
Contribution of KV1.5 Channel to H2O2-Induced Human Arteriolar Dilation and its Modulation by Coronary Artery Disease. Circ Res (2016) 0.75
Identification of plasma vascular endothelia-cadherin as a biomarker for coronary artery disease in Type 2 diabetes mellitus patients. Int J Clin Exp Med (2015) 0.75
Obesity Related Coronary Microvascular Dysfunction: From Basic to Clinical Practice. Cardiol Res Pract (2016) 0.75
Prevalence of overweight and obesity in the United States, 1999-2004. JAMA (2006) 72.59
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA (2002) 18.43
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med (2003) 13.25
Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol (2008) 5.56
The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol (2010) 5.54
Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med (2006) 4.69
Coronary physiology. Physiol Rev (1983) 3.33
Increased vascular smooth muscle contractility in TRPC6-/- mice. Mol Cell Biol (2005) 3.28
Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imaging. J Am Coll Cardiol (2004) 2.97
Regulation of coronary blood flow during exercise. Physiol Rev (2008) 2.84
Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells. Circ Res (2005) 2.79
Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation (2004) 2.73
National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation (2004) 2.65
Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. Am J Med Sci (2001) 2.54
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol (2006) 2.41
Upregulated TRPC1 channel in vascular injury in vivo and its role in human neointimal hyperplasia. Circ Res (2006) 2.22
Alpha-adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute myocardial infarction. Circulation (1999) 2.20
Reduced nitric oxide bioavailability contributes to skeletal muscle microvessel rarefaction in the metabolic syndrome. Am J Physiol Regul Integr Comp Physiol (2005) 2.05
Diabetes mellitus impairs vasodilation to hypoxia in human coronary arterioles: reduced activity of ATP-sensitive potassium channels. Circ Res (2003) 2.01
Impaired function of coronary BK(Ca) channels in metabolic syndrome. Am J Physiol Heart Circ Physiol (2009) 1.89
Classical transient receptor potential channel 6 (TRPC6) is essential for hypoxic pulmonary vasoconstriction and alveolar gas exchange. Proc Natl Acad Sci U S A (2006) 1.89
Matching coronary blood flow to myocardial oxygen consumption. J Appl Physiol (1985) (2004) 1.83
Physiological roles of K+ channels in vascular smooth muscle cells. J Smooth Muscle Res (2008) 1.83
Sympathetic nervous activation in obesity and the metabolic syndrome--causes, consequences and therapeutic implications. Pharmacol Ther (2010) 1.82
The sympathetic nervous system and the metabolic syndrome. J Hypertens (2007) 1.80
Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion. Circ Res (2008) 1.76
TRPV4-mediated endothelial Ca2+ influx and vasodilation in response to shear stress. Am J Physiol Heart Circ Physiol (2009) 1.76
Role of potassium in regulating blood flow and blood pressure. Am J Physiol Regul Integr Comp Physiol (2006) 1.74
Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance. Am J Physiol Heart Circ Physiol (2007) 1.71
Excitation-transcription coupling in arterial smooth muscle. Circ Res (2006) 1.70
Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia (2005) 1.69
Alpha-adrenergic mechanisms in myocardial ischemia. Circulation (1990) 1.68
Flow-induced dilation of human coronary arterioles: important role of Ca(2+)-activated K(+) channels. Circulation (2001) 1.65
Restoration of coronary endothelial function in obese Zucker rats by a low-carbohydrate diet. Am J Physiol Heart Circ Physiol (2007) 1.54
Microvascular dysfunction: a potential pathophysiological role in the metabolic syndrome. Hypertension (2007) 1.53
Aldosterone nongenomically worsens ischemia via protein kinase C-dependent pathways in hypoperfused canine hearts. Hypertension (2005) 1.53
Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function. J Am Coll Cardiol (2006) 1.52
Hydrogen peroxide: a feed-forward dilator that couples myocardial metabolism to coronary blood flow. Arterioscler Thromb Vasc Biol (2006) 1.52
alpha-adrenergic coronary vasoconstriction and myocardial ischemia in humans. Circulation (2000) 1.44
Sympathetic system activity in obesity and metabolic syndrome. Ann N Y Acad Sci (2006) 1.44
Exercise training decreases store-operated Ca2+entry associated with metabolic syndrome and coronary atherosclerosis. Cardiovasc Res (2009) 1.43
Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension. Hypertension (2004) 1.42
TRP channel and cardiovascular disease. Pharmacol Ther (2008) 1.42
Cation channels of the transient receptor potential superfamily: their role in physiological and pathophysiological processes of smooth muscle cells. Pharmacol Ther (2006) 1.41
Epicardial perivascular adipose-derived leptin exacerbates coronary endothelial dysfunction in metabolic syndrome via a protein kinase C-beta pathway. Arterioscler Thromb Vasc Biol (2010) 1.35
Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes. Diabetes (2002) 1.35
Regulation of cardiac and smooth muscle Ca(2+) channels (Ca(V)1.2a,b) by protein kinases. Am J Physiol Cell Physiol (2001) 1.34
Endothelial glycocalyx and coronary vascular permeability: the fringe benefit. Basic Res Cardiol (2010) 1.34
Impaired capsaicin-induced relaxation of coronary arteries in a porcine model of the metabolic syndrome. Am J Physiol Heart Circ Physiol (2008) 1.32
Vascular calcium channels and high blood pressure: pathophysiology and therapeutic implications. Vascul Pharmacol (2006) 1.31
Mediators of sympathetic activation in metabolic syndrome obesity. Curr Hypertens Rep (2008) 1.29
Oxidative stress and potassium channel function. Clin Exp Pharmacol Physiol (2002) 1.28
TRP channels in hypertension. Biochim Biophys Acta (2007) 1.25
Divergent roles of angiotensin II AT1 and AT2 receptors in modulating coronary microvascular function. Circ Res (2003) 1.25
Myocardial and vascular dysfunction and exercise capacity in the metabolic syndrome. Am J Cardiol (2005) 1.24
H2O2 activates redox- and 4-aminopyridine-sensitive Kv channels in coronary vascular smooth muscle. Am J Physiol Heart Circ Physiol (2006) 1.24
Mineralocorticoid receptor activation promotes vascular cell calcification. Arterioscler Thromb Vasc Biol (2007) 1.21
Human coronary arteriolar dilation to bradykinin depends on membrane hyperpolarization: contribution of nitric oxide and Ca2+-activated K+ channels. Circulation (1999) 1.21
Hypertension and obesity. Recent Prog Horm Res (2004) 1.20
A high fat diet increases mitochondrial fatty acid oxidation and uncoupling to decrease efficiency in rat heart. Basic Res Cardiol (2011) 1.19
Hypercholesterolemia inhibits L-type calcium current in coronary macro-, not microcirculation. J Appl Physiol (1985) (2004) 1.18
Mechanisms of coronary dysfunction in obesity and insulin resistance. Microcirculation (2007) 1.16
H2O2-induced redox-sensitive coronary vasodilation is mediated by 4-aminopyridine-sensitive K+ channels. Am J Physiol Heart Circ Physiol (2006) 1.16
Low-flow vascular remodeling in the metabolic syndrome X. Am J Physiol Heart Circ Physiol (2003) 1.14
Elevated glucose impairs cAMP-mediated dilation by reducing Kv channel activity in rat small coronary smooth muscle cells. Am J Physiol Heart Circ Physiol (2003) 1.14
Hypercholesterolemia abolishes voltage-dependent K+ channel contribution to adenosine-mediated relaxation in porcine coronary arterioles. Am J Physiol Heart Circ Physiol (2004) 1.14
Diabetic dyslipidemia and exercise affect coronary tone and differential regulation of conduit and microvessel K+ current. Am J Physiol Heart Circ Physiol (2004) 1.13
Interactions between endothelin and nitric oxide in the regulation of vascular tone in obesity and diabetes. Diabetes (2004) 1.12
Voltage-dependent K+ channels regulate the duration of reactive hyperemia in the canine coronary circulation. Am J Physiol Heart Circ Physiol (2008) 1.12
Augmented adrenergic vasoconstriction in hypertensive diabetic obese Zucker rats. Am J Physiol Heart Circ Physiol (2002) 1.12
Role of potassium channels in coronary vasodilation. Exp Biol Med (Maywood) (2010) 1.12
Aldosterone: role in the cardiometabolic syndrome and resistant hypertension. Prog Cardiovasc Dis (2010) 1.12
Exercise training prevents Ca2+ dysregulation in coronary smooth muscle from diabetic dyslipidemic yucatan swine. J Appl Physiol (1985) (2006) 1.11
Molecular determinants of voltage-gated potassium currents in vascular smooth muscle. Cell Biochem Biophys (2005) 1.11
Activation of native TRPC1/C5/C6 channels by endothelin-1 is mediated by both PIP3 and PIP2 in rabbit coronary artery myocytes. J Physiol (2009) 1.10
Adrenergic coronary vasoconstriction helps maintain uniform transmural blood flow distribution during exercise. Circ Res (1988) 1.10
Exercise training blunts microvascular rarefaction in the metabolic syndrome. Am J Physiol Heart Circ Physiol (2006) 1.10
Enhanced arteriolar alpha-adrenergic constriction impairs dilator responses and skeletal muscle perfusion in obese Zucker rats. J Appl Physiol (1985) (2004) 1.09
Function and production of nitric oxide in the coronary circulation of the conscious dog during exercise. Circ Res (1996) 1.09
Association of obesity with risk of coronary heart disease: findings from the National Health and Nutrition Examination Survey, 1999-2006. Surg Obes Relat Dis (2010) 1.07
Exaggerated cardiovascular stress responses and impaired beta-adrenergic-mediated pressor recovery in obese Zucker rats. Hypertension (2006) 1.07
Impaired left ventricular systolic and diastolic function in patients with metabolic syndrome as assessed by strain and strain rate imaging. Diabetes Res Clin Pract (2009) 1.07
Contribution of endothelin and its receptors to the regulation of vascular tone during exercise is different in the systemic, coronary and pulmonary circulation. Cardiovasc Res (2003) 1.06
Distinct mechanisms for diastolic dysfunction in diabetes mellitus and chronic pressure-overload. Basic Res Cardiol (2011) 1.05
Remodeling of the skeletal muscle microcirculation increases resistance to perfusion in obese Zucker rats. Am J Physiol Heart Circ Physiol (2003) 1.05
Altered mechanism of adenosine-induced coronary arteriolar dilation in early-stage metabolic syndrome. Exp Biol Med (Maywood) (2009) 1.05
Voltage-dependent Ca2+ channels in arterial smooth muscle cells. Kidney Blood Press Res (1997) 1.05
Metabolic syndrome reduces the contribution of K+ channels to ischemic coronary vasodilation. Am J Physiol Heart Circ Physiol (2010) 1.04
Impaired Ca2+-dependent activation of large-conductance Ca2+-activated K+ channels in the coronary artery smooth muscle cells of Zucker Diabetic Fatty rats. Biophys J (2008) 1.04
Control of coronary blood flow during exercise. Exp Biol Med (Maywood) (2002) 1.04
Exercise-induced improvement in vasodilatory function accompanies increased insulin sensitivity in obesity and type 2 diabetes mellitus. J Clin Endocrinol Metab (2006) 1.03
The coronary circulation in diabetes: influence of reactive oxygen species on K+ channel-mediated vasodilation. Vascul Pharmacol (2002) 1.03
Contribution of BK(Ca) channels to local metabolic coronary vasodilation: Effects of metabolic syndrome. Am J Physiol Heart Circ Physiol (2009) 1.02
Sensitization of coronary alpha-adrenoceptor vasoconstriction in the prediabetic metabolic syndrome. Microcirculation (2006) 1.02
Coronary arteriolar vasoconstriction to angiotensin II is augmented in prediabetic metabolic syndrome via activation of AT1 receptors. Am J Physiol Heart Circ Physiol (2005) 1.01
Vascular control in humans: focus on the coronary microcirculation. Basic Res Cardiol (2009) 1.01
Short duration of reactive hyperemia in the forearm of subjects with multiple cardiovascular risk factors. Circ J (2006) 1.01
Feedforward sympathetic coronary vasodilation in exercising dogs. J Appl Physiol (1985) (2000) 1.00
Endothelial and neuro-humoral control of coronary blood flow in health and disease. Rev Physiol Biochem Pharmacol (1990) 1.00
Coronary blood flow regulation in the prediabetic metabolic syndrome. Basic Res Cardiol (2003) 1.00
Increased lymphatic flow in the thoracic duct during manipulative intervention. J Am Osteopath Assoc (2005) 1.98
Impaired function of coronary BK(Ca) channels in metabolic syndrome. Am J Physiol Heart Circ Physiol (2009) 1.89
Aging and muscle fiber type alter K+ channel contributions to the myogenic response in skeletal muscle arterioles. J Appl Physiol (1985) (2009) 1.61
Restoration of coronary endothelial function in obese Zucker rats by a low-carbohydrate diet. Am J Physiol Heart Circ Physiol (2007) 1.54
Hydrogen peroxide: a feed-forward dilator that couples myocardial metabolism to coronary blood flow. Arterioscler Thromb Vasc Biol (2006) 1.52
Leptin receptors are expressed in coronary arteries, and hyperleptinemia causes significant coronary endothelial dysfunction. Am J Physiol Heart Circ Physiol (2005) 1.50
Nitric oxide contributes to oxygen demand-supply balance in hypoperfused right ventricle. Cardiovasc Res (2004) 1.43
Epicardial perivascular adipose-derived leptin exacerbates coronary endothelial dysfunction in metabolic syndrome via a protein kinase C-beta pathway. Arterioscler Thromb Vasc Biol (2010) 1.35
Impaired capsaicin-induced relaxation of coronary arteries in a porcine model of the metabolic syndrome. Am J Physiol Heart Circ Physiol (2008) 1.32
H2O2 activates redox- and 4-aminopyridine-sensitive Kv channels in coronary vascular smooth muscle. Am J Physiol Heart Circ Physiol (2006) 1.24
Perivascular adipose tissue potentiates contraction of coronary vascular smooth muscle: influence of obesity. Circulation (2013) 1.22
Mechanisms of coronary dysfunction in obesity and insulin resistance. Microcirculation (2007) 1.16
H2O2-induced redox-sensitive coronary vasodilation is mediated by 4-aminopyridine-sensitive K+ channels. Am J Physiol Heart Circ Physiol (2006) 1.16
Voltage-dependent K+ channels regulate the duration of reactive hyperemia in the canine coronary circulation. Am J Physiol Heart Circ Physiol (2008) 1.12
Role of potassium channels in coronary vasodilation. Exp Biol Med (Maywood) (2010) 1.12
Redox-dependent coronary metabolic dilation. Am J Physiol Heart Circ Physiol (2007) 1.10
Resistin impairs endothelium-dependent dilation to bradykinin, but not acetylcholine, in the coronary circulation. Am J Physiol Heart Circ Physiol (2006) 1.10
Altered mechanism of adenosine-induced coronary arteriolar dilation in early-stage metabolic syndrome. Exp Biol Med (Maywood) (2009) 1.05
Epicardial perivascular adipose tissue as a therapeutic target in obesity-related coronary artery disease. Br J Pharmacol (2012) 1.05
Metabolic syndrome reduces the contribution of K+ channels to ischemic coronary vasodilation. Am J Physiol Heart Circ Physiol (2010) 1.04
Periadventitial adipose tissue impairs coronary endothelial function via PKC-beta-dependent phosphorylation of nitric oxide synthase. Am J Physiol Heart Circ Physiol (2009) 1.04
Endogenous adipose-derived factors diminish coronary endothelial function via inhibition of nitric oxide synthase. Microcirculation (2008) 1.04
Mechanisms of oxygen demand/supply balance in the right ventricle. Exp Biol Med (Maywood) (2005) 1.02
Sensitization of coronary alpha-adrenoceptor vasoconstriction in the prediabetic metabolic syndrome. Microcirculation (2006) 1.02
Contribution of BK(Ca) channels to local metabolic coronary vasodilation: Effects of metabolic syndrome. Am J Physiol Heart Circ Physiol (2009) 1.02
Dynamic micro- and macrovascular remodeling in coronary circulation of obese Ossabaw pigs with metabolic syndrome. J Appl Physiol (1985) (2012) 1.02
Coronary arteriolar vasoconstriction to angiotensin II is augmented in prediabetic metabolic syndrome via activation of AT1 receptors. Am J Physiol Heart Circ Physiol (2005) 1.01
Leptin and mechanisms of endothelial dysfunction and cardiovascular disease. Curr Hypertens Rep (2008) 1.01
Contribution of adenosine A(2A) and A(2B) receptors to ischemic coronary dilation: role of K(V) and K(ATP) channels. Microcirculation (2010) 1.01
Interactions between A(2A) adenosine receptors, hydrogen peroxide, and KATP channels in coronary reactive hyperemia. Am J Physiol Heart Circ Physiol (2013) 1.00
Coronary blood flow regulation in the prediabetic metabolic syndrome. Basic Res Cardiol (2003) 1.00
Contribution of voltage-dependent K⁺ channels to metabolic control of coronary blood flow. J Mol Cell Cardiol (2011) 0.99
Impaired cardiometabolic responses to glucagon-like peptide 1 in obesity and type 2 diabetes mellitus. Basic Res Cardiol (2013) 0.99
SWI/SNF complexes containing Brahma or Brahma-related gene 1 play distinct roles in smooth muscle development. Mol Cell Biol (2011) 0.98
Bisphenol A activates Maxi-K (K(Ca)1.1) channels in coronary smooth muscle. Br J Pharmacol (2010) 0.98
Adenosine A1 receptors in neointimal hyperplasia and in-stent stenosis in Ossabaw miniature swine. Coron Artery Dis (2008) 0.96
Knockout mice reveal that the angiotensin II type 1B receptor links to smooth muscle contraction. Am J Hypertens (2007) 0.95
Leptin resistance extends to the coronary vasculature in prediabetic dogs and provides a protective adaptation against endothelial dysfunction. Am J Physiol Heart Circ Physiol (2005) 0.92
Intermittent hypoxic training protects canine myocardium from infarction. Exp Biol Med (Maywood) (2004) 0.90
C-reactive protein does not relax vascular smooth muscle: effects mediated by sodium azide in commercially available preparations. Am J Physiol Heart Circ Physiol (2004) 0.90
Phosphatidylinositol 3-kinase inhibitors reveal a unique mechanism of enhancing insulin secretion in 832/13 rat insulinoma cells. Biochem Biophys Res Commun (2004) 0.89
Contribution of voltage-dependent K+ and Ca2+ channels to coronary pressure-flow autoregulation. Basic Res Cardiol (2012) 0.87
Nitric oxide contributes to right coronary vasodilation during systemic hypoxia. Am J Physiol Heart Circ Physiol (2004) 0.86
Adenosine A1 receptors link to smooth muscle contraction via CYP4a, protein kinase C-α, and ERK1/2. J Cardiovasc Pharmacol (2013) 0.86
Dysfunction of cardiac ryanodine receptors in the metabolic syndrome. J Mol Cell Cardiol (2006) 0.86
Bromoenol lactone inhibits voltage-gated Ca2+ and transient receptor potential canonical channels. J Pharmacol Exp Ther (2011) 0.86
Regulation of 130-kDa smooth muscle myosin light chain kinase expression by an intronic CArG element. J Biol Chem (2013) 0.86
Adipokines and coronary vasomotor dysfunction. Exp Biol Med (Maywood) (2007) 0.85
Contribution of electromechanical coupling between Kv and Ca v1.2 channels to coronary dysfunction in obesity. Basic Res Cardiol (2013) 0.84
Contribution of IKCa channels to the control of coronary blood flow. Exp Biol Med (Maywood) (2011) 0.84
Coronary vasomotor reactivity to endothelin-1 in the prediabetic metabolic syndrome. Microcirculation (2006) 0.84
Bisphenol A activates BK channels through effects on α and β1 subunits. Channels (Austin) (2014) 0.83
Alpha-adrenoceptor-mediated coronary vasoconstriction is augmented during exercise in experimental diabetes mellitus. J Appl Physiol (1985) (2004) 0.83
Diabetes mellitus reduces the function and expression of ATP-dependent K⁺ channels in cardiac mitochondria. Life Sci (2012) 0.83
Intracoronary glucagon-like peptide 1 preferentially augments glucose uptake in ischemic myocardium independent of changes in coronary flow. Exp Biol Med (Maywood) (2012) 0.83
Altered calcium signaling in colonic smooth muscle of type 1 diabetic mice. Am J Physiol Gastrointest Liver Physiol (2011) 0.83
Penitrem A as a tool for understanding the role of large conductance Ca(2+)/voltage-sensitive K(+) channels in vascular function. J Pharmacol Exp Ther (2012) 0.81
Reduced molecular expression of K(+) channel proteins in vascular smooth muscle from rats made hypertensive with N{omega}-nitro-L-arginine. Am J Physiol Heart Circ Physiol (2005) 0.81
Glucagon-like peptide-1 (7-36) but not (9-36) augments cardiac output during myocardial ischemia via a Frank-Starling mechanism. Basic Res Cardiol (2014) 0.80
Functional contribution of P2Y1 receptors to the control of coronary blood flow. J Appl Physiol (1985) (2011) 0.80
Nitric oxide modulates right ventricular flow and oxygen consumption during norepinephrine infusion. Am J Physiol Heart Circ Physiol (2002) 0.80
Reduced functional expression of K(+) channels in vascular smooth muscle cells from rats made hypertensive with N{omega}-nitro-L-arginine. Am J Physiol Heart Circ Physiol (2005) 0.80
Bi-ventricular pacing improves pump function only with adequate myocardial perfusion in canine hearts with pseudo-left bundle branch block. Exp Biol Med (Maywood) (2012) 0.79
Cardiovascular and hemodynamic effects of glucagon-like peptide-1. Rev Endocr Metab Disord (2014) 0.78
Role of endothelin in alpha-adrenoceptor coronary vasoconstriction. Am J Physiol Heart Circ Physiol (2004) 0.77
Withdrawal of vasoconstrictor influences in local metabolic coronary vasodilation. Am J Physiol Heart Circ Physiol (2006) 0.77
Diphenyl phosphine oxide-1-sensitive K(+) channels contribute to the vascular tone and reactivity of resistance arteries from brain and skeletal muscle. Microcirculation (2015) 0.77
Leptin-induced endothelial dysfunction: a target for therapeutic interventions. Curr Pharm Des (2014) 0.77
Contribution of hydrogen sulfide to the control of coronary blood flow. Microcirculation (2014) 0.77
Alpha-adrenergic vasoconstrictor tone limits right coronary blood flow in exercising dogs. Exp Biol Med (Maywood) (2004) 0.77
Endogenous nitric oxide regulates right coronary blood flow during acute pulmonary hypertension in conscious dogs. Basic Res Cardiol (2002) 0.76
Hypoxia-induced vasodilation in the right coronary circulation of conscious dogs: role of adrenergic activation. Auton Neurosci (2007) 0.75